Xiaobu Ye

4PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Jun 05, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.

Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz

|Mar 06, 2024
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.

Karisa C Schreck, Roy E Strowd, Louis B Nabors

Pageof 1

Frequent Collaborators

4 joint publications

Louis B Nabors

4 joint publications

Stuart A Grossman

3 joint publications

Patrick Y Wen

3 joint publications

Serena Desideri